ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
GenScript reported 27.3% revenue growth for the first half of 2026. The company's AI drug discovery business doubled during the period, contributing to the overall financial performance.
Tap to vote and see what everyone thinks.
Summary by ByteBrief